A Phase 1/2 Study of Safety and Efficacy of the Arginase Inhibitor INCB001158 Plus Chemotherapy in Patients With Advanced or Metastatic Biliary Tract Cancers
A Phase 1/2 Study of Safety and Efficacy of the Arginase Inhibitor INCB001158 Plus Chemotherapy in Patients With Advanced or Metastatic Biliary Tract Cancers